IJCS | Volume 31, Nº3, May/ June 2018

207 1. Gold EB, Crawford SL, Avis NE, Crandall CJ, Matthews KA, Waetjen LE, et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol. 2013;178(1):70-83. doi: 10.1093/ aje/kws421. 2. Instituto Brasileiro de Geografia e Estatística (IBGE). Síntese de indicadores sociais: uma análise das condições de vida da população brasileira. [Internet]. 2010. [Acesso em 2015 jul 16]. Disponível em: http:www.ibge.gov.br/home/estatistica/populacao/condicoesde vida/ indicadoresminimos/sinteseindicsociais2010/SIS_2010.pdf.3 3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Clement JI, Donato KA, et al. Harmonizing the metabolic syndrome: a Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. doi: 10.1161/ CIRCULATIONAHA.109.192644. 4. Gobato AO, Vasques AC, Zambon MP, Barros Filho AA, Hessel G. Metabolic syndrome and insulin resistance in obese adolescents. Rev Paul Pediatr. 2014;32(1):55-62. doi: http://dx.doi.org/10.1590/S0103- 05822014000100010. 5. Vasques AC, Rosado LH, Alfenas RC, Geleneze B. Critical analysis on the use of the homeostasis hodel assessment (HOMA) indexes in the evaluation of the insulin resistance and the pancreatic beta cells functional capacity. Arq Bras Endocrinol Metab. 2008;52(1):32-9. doi: http://dx.doi.org/10.1590/S0004-27302008000100006. 6. Lainscak M, Haehling S, Anker SD. Natriuretic peptides and other biomarkers in chronic heart failure: fromBNP, NT-pró BNP, andMR-pro ANP to routine biochemical markers. Int J Cardiol. 2009;132(3):303-11. doi: 10.1016/j.ijcard.2008.11.149. 7. Sociedade Brasileira de Cardiologia; Sociedade Brasileira de Hipertensão; Sociedade Brasileira de Nefrologia. [VI Brazilian Guidelines on Hypertension]. Arq Bras Cardiol. 2010;95(1 Suppl):1-51. PMID: 21085756. Erratum in: Arq Bras Cardiol. 2010;95(4):553. 8. Sociedade Brasileira de Diabetes.. Diagnóstico e classificação do Diabetes Mellitus do tipo 2. Consenso Brasileiro sobre Diabetes. [Acesso em 2015 jan 10]. Disponível em: http://www.c:/bvs/editavles/pdf/ consensoSBD.doc. 9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations inman. Diabetologia. 1985;28(7):412-9. PMID: 3899825. 10. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005;54(2):333-9. PMID: 15677489. 11. Allal-Elasmi M, Taieb SH, Hsairi M, Zayani Y, Omar S, Sanhaji H, et al. The metabolic syndrome: prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis. Diabetes Metab. 2010;36(3):204-8. doi: 10.1016/j.diabet.2009.11.009. 12. Mendes KG. Estadomenopáusico e síndromemetabólica emmulheres no climatério atendidas em um ambulatório no Sul do Brasil [Dissertação]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2012. 13. Figueiredo Neto JA, Figueiredo ED, Barbosa JB, Barbosa Fde F, Costa GR, Nina VJ, et al. Metabolic syndrome and menopause: cross-sectional study in gynecology clinic. Arq Bras Cardiol. 2010;95(3):339-45. doi: http://dx.doi.org/10.1590/S0066-782X2010005000094. 14. Ali SB, Belfki-Benali H, Aounallah-Skhiri H, Traissac P, Maire B, Delpeuch F, et al. Menopause and metabolic syndrome in Tunisian women. BioMed Research International. 2014; Article ID 457131, 7 pages. doi: https://dx.doi.org/10.1155/2014/457131. 15. Cho GJ, Lee JH, ParkHT, Shin JH, Hong SC, KimT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause. 2008;15(3):524-9. doi: 10.1097/ gme.0b013e3181559860. 16. Arthur FK, Adu-Frimpong M, Osei-Yeboah J, Mensah FO, Owusu L. The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaianwomen. BMCRes Notes. 2013 Nov 8;6:446. doi: 10.1186/1756-0500-6-446. 17. Jouyandeh Z, Nayebzadeh F, Qorbani M, Asadi M. Metabolic syndrome andmenopause. J DiabetesMetabDisord. 2013;12(1):1. doi: 10.1186/2251- 6581-12-1 References Fonseca et al. Metabolic Syndrome and Insulin Resistance International Journal of Cardiovascular Sciences. 2018;31(3)201-208 Original Article Author contributions Conception and design of the research: Fonseca EJNC, Figueredo Neto JA. Acquisition of data: : Fonseca EJNC, Silva BL, Figueredo Neto JA, Rocha TPO, Melo JB, Andrade MVG, Sousa SMB, Lopes EJ, Lopes EJ. Analysis and interpretation of the data: Fonseca EJNC, Serra CB, Figueredo Neto JA. Statistical analysis: Fonseca EJNC, Nogueira IAL, Figueredo Neto JA. Obtaining financing: Fonseca EJNC, Nogueira IAL, Figueredo Neto JA, Melo JB. Writing of the manuscript: Fonseca EJNC, Figueredo Neto JA. Critical revision of the manuscript for intellectual content: Fonseca EJNC, Nogueira IAL, Figueredo Neto JA, Rocha TPO. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding This study was funded by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) e à Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão (FAPEMA). Study Association This article is part of the thesis of master submitted by Érika Joseth Nogueira da Cruz Fonseca, from Universidade Federal do Maranhão. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Hospital Universitário da Universidade Federal do Maranhão under the protocol number 005900/2011‑00. All the procedures in this studywere in accordancewith the 1975HelsinkiDeclaration, updatedin2013. Informedconsent was obtained from all participants included in the study.